Sapient Capital LLC Y M Abs Therapeutics, Inc. Transaction History
Sapient Capital LLC
- $4.73 Billion
- Q2 2024
A detailed history of Sapient Capital LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Sapient Capital LLC holds 43,700 shares of YMAB stock, worth $611,363. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,700
Previous 43,700
-0.0%
Holding current value
$611,363
Previous $711 Million
99.93%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
96Shares Held
23.8MCall Options Held
19.4KPut Options Held
300-
Paradigm Biocapital Advisors LP New York, NY3.87MShares$54.1 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$41.1 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$30.7 Million1.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$27.4 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$25.6 Million0.13% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $612M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...